Anti-inflammatory, immunologic and carcinostatic attributes of selenium in experimental animals.
D000818:Animals; D000893:Anti-Inflammatory Agents; D000917:Antibody Formation / Q000187:drug effects*; D000970:Antineoplastic Agents; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004912:Erythrocytes / Q000276:immunology; D006386:Hemagglutination Tests; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced; D007111:Immunity, Cellular / Q000187:drug effects; D007121:Immunocompetence / Q000187:drug effects; D009751:Nutritional Requirements; D064586:Selenic Acid; D012643:Selenium / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D018036:Selenium Compounds; D014810:Vitamin E / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D018036:Selenium Compounds; D014810:Vitamin E; D012643:Selenium; D064586:Selenic Acid